NCT05343624View on ClinicalTrials.gov

Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Covid19Diabetes Mellitus
Interventions
DEVICE

continuous glucose monitoring

Use of continuous glucose monitoring in inpatient and ICU settings

Trial Locations (1)

44106

University Hospitals Cleveland Medical center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT05343624 - Use of Continuous Glucose Monitors in Coronavirus Disease 2019 ICU and Potential Inpatient Settings | Biotech Hunter | Biotech Hunter